REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,390 | -7.4% | 33,250 | -17.4% | 0.82% | -13.5% |
| Q1 2023 | $3,660 | +103.9% | 40,250 | -14.8% | 0.95% | +94.7% |
| Q4 2022 | $1,795 | -99.8% | 47,250 | 0.0% | 0.49% | +35.8% |
| Q3 2022 | $1,187,000 | -17.3% | 47,250 | 0.0% | 0.36% | -11.8% |
| Q2 2022 | $1,436,000 | -7.2% | 47,250 | 0.0% | 0.41% | -11.5% |
| Q1 2022 | $1,548,000 | +24.2% | 47,250 | 0.0% | 0.46% | +37.0% |
| Q4 2021 | $1,246,000 | -79.6% | 47,250 | -22.2% | 0.34% | -80.6% |
| Q3 2021 | $6,112,000 | -46.7% | 60,750 | -25.0% | 1.73% | -44.0% |
| Q2 2021 | $11,464,000 | +6.5% | 81,000 | -25.0% | 3.09% | -5.0% |
| Q1 2021 | $10,768,000 | – | 108,000 | – | 3.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $110,053,269 | 27.64% |
| Ghost Tree Capital, LLC | 500,000 | $18,995,000 | 8.11% |
| First Light Asset Management, LLC | 2,062,453 | $78,352,589 | 7.27% |
| Boxer Capital, LLC | 1,230,004 | $46,727,852 | 2.46% |
| Sofinnova Investments, Inc. | 992,029 | $37,687,182 | 2.24% |
| Tri Locum Partners LP | 141,466 | $5,374,000 | 2.17% |
| MPM BioImpact LLC | 194,181 | $7,376,936 | 1.91% |
| Ikarian Capital, LLC | 201,200 | $7,643,588 | 1.84% |
| KRS Capital Management, LLC | 28,141 | $1,069,077 | 1.46% |
| EMERALD ADVISERS, LLC | 679,772 | $25,824,538 | 1.25% |